Jones C - Search Results

1

The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study.

Kapur S, Zipursky R, Roy P, Jones C, Remington G, Reed K, Houle S. Kapur S, et al. Among authors: jones c. Psychopharmacology (Berl). 1997 May;131(2):148-52. doi: 10.1007/s002130050277. Psychopharmacology (Berl). 1997. PMID: 9201802

2

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.

Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1996 Jul;153(7):948-50. doi: 10.1176/ajp.153.7.948. Am J Psychiatry. 1996. PMID: 8659621 Clinical Trial.

3

The D2 receptor occupancy profile of loxapine determined using PET.

Kapur S, Zipursky RB, Jones C, Remington GJ, Wilson AA, DaSilva J, Houle S. Kapur S, et al. Among authors: jones c. Neuropsychopharmacology. 1996 Dec;15(6):562-6. doi: 10.1016/S0893-133X(96)00100-5. Neuropsychopharmacology. 1996. PMID: 8946430

4

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

Kapur S, Zipursky R, Remington G, Jones C, McKay G, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1997 Nov;154(11):1525-9. doi: 10.1176/ajp.154.11.1525. Am J Psychiatry. 1997. PMID: 9356559

5

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1998 Jul;155(7):921-8. doi: 10.1176/ajp.155.7.921. Am J Psychiatry. 1998. PMID: 9659858 Clinical Trial.

6

Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy.

Kapur S, Cho R, Jones C, McKay G, Zipursky RB. Kapur S, et al. Among authors: jones c. Biol Psychiatry. 1999 May 1;45(9):1217-20. doi: 10.1016/s0006-3223(98)00204-2. Biol Psychiatry. 1999. PMID: 10331115

7

Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.

Fitzgerald PB, Kapur S, Caligiuri MP, Jones C, Silvestri S, Remington G, Zipursky RB. Fitzgerald PB, et al. Among authors: jones c. Neuropsychopharmacology. 2000 Jan;22(1):19-26. doi: 10.1016/S0893-133X(99)00081-0. Neuropsychopharmacology. 2000. PMID: 10633487 Clinical Trial.

8

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Kapur S, Zipursky R, Jones C, Remington G, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 2000 Apr;157(4):514-20. doi: 10.1176/appi.ajp.157.4.514. Am J Psychiatry. 2000. PMID: 10739409 Clinical Trial.

9

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.

Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P. Kapur S, et al. Among authors: jones c. Arch Gen Psychiatry. 2000 Jun;57(6):553-9. doi: 10.1001/archpsyc.57.6.553. Arch Gen Psychiatry. 2000. PMID: 10839333 Clinical Trial.

10

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F. Wadenberg ML, et al. Among authors: jones c. Psychopharmacology (Berl). 2000 Jul;150(4):422-9. doi: 10.1007/s002130000466. Psychopharmacology (Berl). 2000. PMID: 10958084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,632 results

Search Page

Filters